Foundayo is not a “Mounjaro pill”. It contains orforglipron, while Mounjaro contains tirzepatide. They are different medicines, with different receptor targets and dosing instructions. [1] [3]
What is Foundayo?
Foundayo (orforglipron) is a prescription tablet taken once daily. It is used with a reduced-calorie diet and increased physical activity for weight management in eligible adults. This article compares the two medicines for adult weight management in the UK. [1] [2]
What is Mounjaro?
Mounjaro (tirzepatide) is a prescription injection given under the skin once a week. It is also used with a reduced-calorie diet and increased physical activity for weight management in eligible adults. It activates both GLP-1 and GIP receptors. [3] [4]
How do Foundayo and Mounjaro work?
Both medicines activate GLP-1 receptors involved in appetite and blood glucose regulation. They can reduce hunger and food intake, and both slow stomach emptying. These effects vary between people; feeling full quickly or for a particular length of time is not guaranteed. [1] [3]
GIP is released from the gut after eating and helps stimulate insulin release from the pancreas when blood glucose is raised. Mounjaro activates GIP receptors as well as GLP-1 receptors. Insulin is released by pancreatic beta cells, not by intestinal cells. [3]
Does targeting more receptors make Mounjaro better?
The number of receptor targets alone cannot tell you which treatment will suit you better. Trials have studied different doses, and results depend on the participants, study design and how outcomes are analysed. A higher average weight reduction in one study does not by itself establish that a medicine is the best choice for every patient. [5] [6]
The main weight-loss trials cited here, ATTAIN-1 for orforglipron and SURMOUNT-1 for tirzepatide, compared each medicine with placebo rather than directly with each other. Their results should not be presented as a head-to-head comparison. Individual responses also vary. [5] [6]
ATTAIN-MAINTAIN studied orforglipron versus placebo after previous treatment with tirzepatide or semaglutide. It did not compare switching to orforglipron with continuing those injections, so it does not show that switching preserves the same benefit as ongoing Mounjaro treatment. [7]
How do side effects and suitability differ?
Both medicines can cause digestive side effects, including nausea, vomiting, diarrhoea, constipation and bloating. This overlap does not mean their side effects occur equally often or that the medicines have identical safety profiles. Mounjaro can also cause injection-site reactions, while the interaction checks for Foundayo differ. [1] [2] [3] [4]
Read the leaflet for your own medicine. If you develop severe, persistent abdominal pain, which may spread to the back, with or without nausea or vomiting, stop the medicine and seek urgent medical help because this could be pancreatitis. [1] [3]
Evidence continues to develop. Your prescriber should consider the current product information alongside your treatment response and any side effects.
Your prescriber can assess which option, if either, is appropriate after reviewing your medical history, other medicines, treatment goals and preferences. A daily tablet and a weekly injection involve different routines, but convenience is only one part of the decision. [8]
Foundayo and Mounjaro: practical comparison
The practical comparison below summarises key differences. The medicines have separate dosing instructions and cannot be swapped milligram for milligram. [1] [3] [8]
| Feature | Foundayo | Mounjaro |
|---|---|---|
| Active ingredient | Orforglipron | Tirzepatide |
| How it is taken | Tablet swallowed whole | Injection under the skin |
| Usual frequency | Once daily | Once weekly |
| Receptor targets | GLP-1 | GLP-1 and GIP |
| Meals | With or without food | With or without meals |
| Available strengths (not equivalent) | 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Dose selection | Its own gradual dose schedule; follow your prescription | Its own gradual dose schedule; follow your prescription |
Dosing and meal instructions are taken from the UK patient information leaflets. [2] [4]
Discussing a change of treatment
If you want to change treatment, discuss it with your prescriber. Do not switch, combine the two medicines or choose a replacement dose yourself. Ask for a clear plan covering the last dose of the old medicine and the first dose of the new one. [8]
